These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26048133)

  • 21. Common pathogens in burn wound and changes in their drug sensitivity.
    Rezaei E; Safari H; Naderinasab M; Aliakbarian H
    Burns; 2011 Aug; 37(5):805-7. PubMed ID: 21388742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of resistance phenotype and homology of Klebsiella pneumoniae in burn patients].
    Liu XL; Peng DZ; Xue L; Shu WT; Zhou X; Liu J
    Zhonghua Shao Shang Za Zhi; 2012 Apr; 28(2):96-100. PubMed ID: 22781319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of tigecycline against resistant micro-organisms isolated from burn patients.
    Timurkaynak F; Arslan H; Azap OK; Senger SS; Başaran O; Karaman SO; Haberal M
    Burns; 2008 Nov; 34(7):1033-6. PubMed ID: 18539397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of multidrug-resistant organisms recovered at a military burn center.
    Keen EF; Robinson BJ; Hospenthal DR; Aldous WK; Wolf SE; Chung KK; Murray CK
    Burns; 2010 Sep; 36(6):819-25. PubMed ID: 20080354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudomonas aeruginosa prevalence, antibiotic resistance and antimicrobial use in Chinese burn wards from 2007 to 2014.
    Dou Y; Huan J; Guo F; Zhou Z; Shi Y
    J Int Med Res; 2017 Jun; 45(3):1124-1137. PubMed ID: 28443385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbiological safety and clinical efficacy of radiation sterilized amniotic membranes for treatment of second-degree burns.
    Singh R; Purohit S; Chacharkar MP; Bhandari PS; Bath AS
    Burns; 2007 Jun; 33(4):505-10. PubMed ID: 17182190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of some plant extracts and antibiotics on Pseudomonas aeruginosa isolated from various burn cases.
    Al-Saimary IE; Bakr SS; Jaffar T; Al-Saimary AE; Salim H; Al-Muosawi R
    Saudi Med J; 2002 Jul; 23(7):802-5. PubMed ID: 12174229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spread of extended-spectrum β-lactamase genes of blaOXA-10, blaPER-1 and blaCTX-M in Pseudomonas aeruginosa strains isolated from burn patients.
    Farshadzadeh Z; Khosravi AD; Alavi SM; Parhizgari N; Hoveizavi H
    Burns; 2014 Dec; 40(8):1575-80. PubMed ID: 24767142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vitro antibacterial activity of Curcuma longa (Zingiberaceae) against nosocomial bacteria in Montería, Colombia].
    Méndez Álvarez N; Angulo Ortíz A; Contreras Martínez O
    Rev Biol Trop; 2016 Sep; 64(3):1201-8. PubMed ID: 29462537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Neyestanaki DK; Mirsalehian A; Rezagholizadeh F; Jabalameli F; Taherikalani M; Emaneini M
    Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of the types of microorganisms isolated from blood and wounds on the results of treatment in burn patients with sepsis.
    Glik J; Kawecki M; Gaździk T; Nowak M
    Pol Przegl Chir; 2012 Jan; 84(1):6-16. PubMed ID: 22472489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of drug resistance of Pseudomonas aeruginosa and use of antibiotics in burn wards during 6 years].
    Dou Y; Zhang Q
    Zhonghua Shao Shang Za Zhi; 2014 Feb; 30(1):9-14. PubMed ID: 24684983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spectrum and drug resistance of pathogens from patients with burns.
    Sun FJ; Zhang XB; Fang Y; Chen J; Xing H; Shi H; Feng W; Xia P
    Burns; 2012 Dec; 38(8):1124-30. PubMed ID: 22795514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Surveillance of multidrug resistant bacteria in a Tunisian hospital].
    Thabet L; Messadi Aa; Mbarek M; Turki A; Meddeb B; Ben Redjeb S
    Tunis Med; 2008 Nov; 86(11):992-5. PubMed ID: 19213491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In vitro antibacterial activity of sulperazone on multi-resistant strains of bacteria from burn wounds].
    Xu W; Chen X
    Zhonghua Wai Ke Za Zhi; 1995 Jul; 33(7):390-2. PubMed ID: 8565723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical significance of the predominant bacterial strains on burn wound during early postburn stage].
    Li TZ; Luo L; Xu YB; Deng XX; Liu S; Fan GY; Qi SH
    Zhonghua Shao Shang Za Zhi; 2003 Apr; 19(2):71-4. PubMed ID: 12812628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stochasticity among Antibiotic-Resistance Profiles of Common Burn-Related Pathogens over a Six-Year Period.
    Collier ZJ; Gottlieb LJ; Alverdy JC
    Surg Infect (Larchmt); 2017 Apr; 18(3):327-335. PubMed ID: 28394746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of susceptibility of Pseudomonas aeruginosa isolated from a burn ward to antibiotics in vitro].
    Zhang YH; Deng SL; Liu JW
    Zhonghua Shao Shang Za Zhi; 2005 Apr; 21(2):104-6. PubMed ID: 15938955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of topical antimicrobial agents against multidrug-resistant bacteria recovered from burn patients.
    Glasser JS; Guymon CH; Mende K; Wolf SE; Hospenthal DR; Murray CK
    Burns; 2010 Dec; 36(8):1172-84. PubMed ID: 20542641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imparting commercial antimicrobial dressings with low-adherence to burn wounds.
    Asghari S; Logsetty S; Liu S
    Burns; 2016 Jun; 42(4):877-83. PubMed ID: 26847614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.